A comprehensive assessment of the association between common drugs and psychiatric disorders using Mendelian randomization and real-world pharmacovigilance database.
使用孟德爾隨機化和實際世界藥物監測數據庫對常見藥物與精神疾病之間的關聯進行全面評估。
EBioMedicine 2024-08-27
The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase.
抗糖尿病藥物的潛在抗憂鬱作用:基於 FAERS 和 VigiBase 報告系統數據的藥物監察研究。
Front Pharmacol 2023-03-07
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database.
與semaglutide、liraglutide和tirzepatide相關的精神科不良事件:提交至EudraVigilance數據庫的個別案例安全報告的藥物警戒分析。
Int J Clin Pharm 2024-03-26
The risk of common hypoglycemic and antihypertensive medications and COVID-19: A 2-sample Mendelian randomization study.
常見降血糖和降壓藥物對 COVID-19 的風險:一項雙樣本Mendelian randomization研究。
Medicine (Baltimore) 2024-02-14
Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database.
GLP-1 受體激動劑與自殺或自我傷害行為之潛在關聯性探討:基於 FDA 不良事件報告系統資料庫的藥物監察研究。
BMC Med 2024-02-17
Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database.
GLP-1 受體激動劑相關的精神疾病不良事件:基於 FDA 不良事件報告系統數據的實際世界藥物警戒研究。
Front Endocrinol (Lausanne) 2024-03-06
Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis.
探討自殺念頭、自我傷害與 GLP-1 受體激動劑在減重治療中的關聯:來自藥物監察措施和揭示分析的見解。
Eur Neuropsychopharmacol 2024-05-02
Glucagon-like-peptide 1 receptor agonism and attempted suicide: A Mendelian randomisation study to assess a potential causal association.
葡萄糖樣肽-1 受體激動劑與自殺企圖:一項孟德爾隨機化研究評估潛在的因果關係。
Clin Obes 2024-05-23
Association between glucagon-like peptide-1 receptor agonists and risk of suicidality: A comprehensive analysis of the global pharmacovigilance database.
胰高血糖素樣肽-1 受體激動劑與自殺風險之間的關聯:全球藥物監測數據庫的綜合分析。
Diabetes Obes Metab 2024-08-20
Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study.
與抗糖尿病藥物相關的運動障礙:一項真實世界的藥物監測研究。
Prog Neuropsychopharmacol Biol Psychiatry 2024-08-25